DE60332257D1 - Verfahren zur bestimmung von anfälligkeit einer person zur infektion - Google Patents

Verfahren zur bestimmung von anfälligkeit einer person zur infektion

Info

Publication number
DE60332257D1
DE60332257D1 DE60332257T DE60332257T DE60332257D1 DE 60332257 D1 DE60332257 D1 DE 60332257D1 DE 60332257 T DE60332257 T DE 60332257T DE 60332257 T DE60332257 T DE 60332257T DE 60332257 D1 DE60332257 D1 DE 60332257D1
Authority
DE
Germany
Prior art keywords
infection
determining
subject
nervation
person
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332257T
Other languages
English (en)
Inventor
Hans Boman
Mats Andersson
Katrin Puetsep
Goeran Carlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mabtech AB
Original Assignee
Mabtech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mabtech AB filed Critical Mabtech AB
Application granted granted Critical
Publication of DE60332257D1 publication Critical patent/DE60332257D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60332257T 2002-10-10 2003-10-10 Verfahren zur bestimmung von anfälligkeit einer person zur infektion Expired - Lifetime DE60332257D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223655.2A GB0223655D0 (en) 2002-10-10 2002-10-10 Method of diagnosis
PCT/EP2003/011240 WO2004034061A2 (en) 2002-10-10 2003-10-10 Method for determining the susceptibility of a subject to infection

Publications (1)

Publication Number Publication Date
DE60332257D1 true DE60332257D1 (de) 2010-06-02

Family

ID=9945734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332257T Expired - Lifetime DE60332257D1 (de) 2002-10-10 2003-10-10 Verfahren zur bestimmung von anfälligkeit einer person zur infektion

Country Status (9)

Country Link
US (1) US7591997B2 (de)
EP (1) EP1549957B1 (de)
JP (1) JP4874545B2 (de)
AT (1) ATE465411T1 (de)
AU (1) AU2003282027B2 (de)
CA (1) CA2501926A1 (de)
DE (1) DE60332257D1 (de)
GB (1) GB0223655D0 (de)
WO (1) WO2004034061A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
RU2010114049A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Cgrp в качестве терапевтического средства
CA2699087A1 (en) * 2007-09-11 2009-04-16 Dorian Bevec Use of a peptide as a therapeutic agent
US20190300575A1 (en) * 2018-03-29 2019-10-03 Deetex, LLC Lytic peptide biosensor and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159936A (en) * 1993-07-20 2000-12-12 The Regents Of The University Of California Compositions and methods for treating and preventing microbial and viral infections
US5972594A (en) 1997-02-05 1999-10-26 University Of Pittsburgh Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins
FR2767832B1 (fr) 1997-08-29 2001-08-10 Genset Sa Polypeptide defensine humaine def-x, adn genomique et adnc, composition les contenant et applications au diagnostic et au traitement therapeutique
AU744152B2 (en) * 1997-09-10 2002-02-14 Zymogenetics Inc. Beta-defensins
JP2001288105A (ja) 2000-04-05 2001-10-16 Yoshihiro Abiko 歯周炎用医薬
DE10028725B4 (de) 2000-06-09 2013-03-21 Jürgen Bux Primärstruktur des HNA-2a (ehemals NB1)-Antigens
JP2004504603A (ja) * 2000-07-17 2004-02-12 ハンサ　メディカル　アクチボラゲット 抗微生物剤
CA2418854A1 (en) * 2000-08-17 2002-02-21 Jorg Fritz A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
US20020072495A1 (en) 2000-09-21 2002-06-13 Oleg Chertov LL-37 is an immunostimulant
WO2002060468A2 (en) * 2001-01-30 2002-08-08 University Of Iowa Research Foundation Antiviral activities of primate theta defensins and mammalian cathelicidins
US20030175755A1 (en) 2002-03-05 2003-09-18 Yoshihiro Abiko Method of collecting data for estimation of susceptibility to periodontal disease

Also Published As

Publication number Publication date
WO2004034061A2 (en) 2004-04-22
JP2006502395A (ja) 2006-01-19
WO2004034061A3 (en) 2004-05-21
CA2501926A1 (en) 2004-04-22
JP4874545B2 (ja) 2012-02-15
AU2003282027A1 (en) 2004-05-04
EP1549957B1 (de) 2010-04-21
AU2003282027B2 (en) 2010-05-13
US7591997B2 (en) 2009-09-22
EP1549957A2 (de) 2005-07-06
ATE465411T1 (de) 2010-05-15
US20070059691A1 (en) 2007-03-15
GB0223655D0 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
DE602005016212D1 (de) System oder verfahren zur beurteilung der peripheren blutzirkulation einer person
EA200600452A1 (ru) Автоматизированные способы и системы для обнаружения и анализа сосудистых бляшек
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE60007304D1 (de) Verfahren zur kryopräservierung von blutgefässen durch glasbildung
DE60315829D1 (de) Automatisches verfahren und vorrichtung zur bestimmung des zustandes von bohrlochoperationen
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
DE60304755D1 (de) Vorrichtung zur Bestimmung von Thrombosen tiefliegender Venen
DE60319426D1 (de) Verfahren zur bestimmung von azimut- undhöhenwinkeln durch verwendung eines einachsen-richtungfindungssystems
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE69941044D1 (de) Methoden, Apparat und Computerprogramm zur quantitativen Bestimmung von Nukleinsäurensequenzen in Proben unter Verwendung von Standardkurven und Abschätzungen von Amplifikationsverhältnissen
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
DE60326827D1 (de) System und verfahren zum erkennen von bösartigem code
DE3882058D1 (de) Immunoreaktives reagens, verfahren zu seiner herstellung und seine verwendung zur bestimmung einer immunoreaktiven spezies.
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
DE69105978D1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
ATE532073T1 (de) Verfahren zur identifizierung einer untersuchungsperson in gefahr, an herzversagen zu erkranken, durch bestimmung des galectin-3- oder thrombospondin-2-spiegels
DE60321356D1 (de) Verfahren zur diagnostik von eierstock endometriose
DE60332257D1 (de) Verfahren zur bestimmung von anfälligkeit einer person zur infektion
DE60111595D1 (de) Verfahren zur Identifizierung von Verbindungen der Wesens als Therapeutika
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
DE50204097D1 (de) Verfahren zur ermittlung von auswirkungen von konstruktionsentscheidungen
ATE470147T1 (de) Verfahren und mittel zur bestimmung von gesamthärte
DE602006007734D1 (de) Verfahren und system zur echtzeitanalyse von biosensordaten
DE602006011748D1 (de) Mikrosensor zur Bestimmung von D-Aminosäuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition